Crossfund Sicav-Cross.Healthcare Fd.B/ LU1334634612 /
NAV22/08/2024 | Var.+0.5600 | Type of yield | Focus sugli investimenti | Società d'investimento |
---|---|---|---|---|
172.2000USD | +0.33% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Performance mensile
gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 0.70 | 0.32 | 0.24 | 4.62 | -1.02 | 2.44 | 3.12 | 1.82 | -4.64 | 3.87 | -4.22 | 5.90 | +13.33% |
2022 | -7.86 | -1.49 | 4.11 | -5.45 | -0.11 | -2.12 | 2.23 | -5.77 | -2.81 | 8.28 | 2.52 | -0.03 | -9.24% |
2023 | -2.04 | -3.09 | 1.72 | 3.71 | -3.98 | 3.52 | -0.18 | -1.16 | -2.90 | -5.85 | 4.33 | 6.04 | -0.64% |
2024 | 3.07 | 2.48 | 2.57 | -4.67 | 2.28 | 2.59 | 1.33 | 3.69 | - | - | - | - | - |
Calculated values
YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
---|---|---|---|---|---|
Volatilità | 10.78% | 11.22% | 11.00% | 12.72% | -% |
Indice di Sharpe | 1.76 | 0.90 | 1.05 | -0.19 | - |
Mese migliore | +6.04% | +3.69% | +6.04% | +8.28% | - |
Mese peggiore | -4.67% | -4.67% | -5.85% | -7.86% | - |
Perdita massima | -6.44% | -6.44% | -10.97% | -19.98% | - |
Outperformance | - | - | - | - | - |
Tutte le quotazioni in USD
Tranches
Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
---|---|---|---|---|---|
Crossfund Sicav-Cross.Healthcare... | reinvestment | 142.5600 | +11.10% | -5.31% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 150.6300 | +13.85% | -1.56% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 176.9500 | +15.34% | +4.29% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 139.2100 | +10.69% | -6.37% | |
Crossfund Sicav-Cross.Healthcare... | reinvestment | 172.2000 | +15.05% | +3.23% | |
CROSSFUND SICAV - Crossinvest He... | reinvestment | 146.9300 | +13.40% | -2.71% |
Prestazione
YTD | +13.87% | ||
---|---|---|---|
6 mesi | +6.59% | ||
1 anno | +15.05% | ||
3 anni | +3.23% | ||
5 anni | - | ||
10 anni | - | ||
Dall'inizio | +16.68% | ||
Anno | |||
2023 | -0.64% | ||
2022 | -9.24% | ||
2021 | +13.33% |